C21 · Pharmaceuticals · DE
New medicine launches in Germany
Germany: 57% (chemically synthesized share of new medicine launches, 2025).
- 57% Latest · 2025
- 4Records · 4 measures
Annual · 1 publisher · Next period 2026
Every record
4 records across 4 measures, newest first within each. Each period opens its record and evidence.
Frequently asked questions
What is the latest new medicine launches figure for Germany?
Germany: 57% chemically synthesized share of new medicine launches in 2025.
Where does the Germany data come from?
4 records from 1 document by VFA. Each figure links to its record and its original source evidence.
Cite this page
Free to reuse under CC BY 4.0 with attribution to StatOrigin and the original publisher.
StatOrigin. (2026). New medicine launches in Germany [Data set]. Retrieved October 28, 2026, from https://statorigin.org/statistics/new-medicine-launches/germany
"New medicine launches in Germany." StatOrigin, 2026, https://statorigin.org/statistics/new-medicine-launches/germany. Accessed 28 Oct. 2026.
StatOrigin. "New medicine launches in Germany." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/statistics/new-medicine-launches/germany.
@misc{statorigin_new_medicine_launches_germany_2026, title = {New medicine launches in Germany}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/statistics/new-medicine-launches/germany}, note = {Data set. Accessed 2026-10-28} }